Tooth Margaret
CEO
- Shares
- 1,000
- Price
- $25.84
- Value
- $25,840
TRUP
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$379,559
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$2,521,395
5 distinct insiders
Highlighted alerts
6
29 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
TRUP overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Restricted stock units convert into common stock on a one-for-one basis. This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person. On February 27, 2024, the reporting person was granted 5,000 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on February 22, 2025, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. On August 19, 2024, the reporting person was granted 48,679 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on August 22, 2025, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date. On February 27, 2025, the reporting person was granted 50,000 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/8th of the total shares on May 22, 2025, after which 1/8th of the total shares vest quarterly, subject to continued service through each vest date. On February 20, 2026, the reporting person was granted 65,497 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/8th of the total shares on May 22, 2026, after which 1/8th of the total shares vest quarterly, subject to continued service through each vest date. On August 14, 2023, the reporting person was granted 20,000 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on August 25, 2024, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
Reason: tax_withholding. The filing footnotes identify tax withholding.
Voluntary purchases and sales; administrative noise stays hidden.
Tooth Margaret
CEO
GALLAGHER JOHN R
Chief Operating Officer
Tooth Margaret
CEO
GALLAGHER JOHN R
Chief Operating Officer
Qureshi Fawwad
Chief Financial Officer
Tooth Margaret
CEO
GALLAGHER JOHN R
Chief Operating Officer
GALLAGHER JOHN R
Chief Operating Officer
WEINRAUCH STEVE
EVP, North Am & Vet Strategy
GALLAGHER JOHN R
Chief Operating Officer
Qureshi Fawwad
Chief Financial Officer
Qureshi Fawwad
Chief Financial Officer
GALLAGHER JOHN R
Chief Operating Officer
GALLAGHER JOHN R
Chief Operating Officer
DREYER EMILY
Chief Revenue Officer
Qureshi Fawwad
Chief Financial Officer
GALLAGHER JOHN R
Chief Operating Officer
Qureshi Fawwad
Chief Financial Officer
GALLAGHER JOHN R
Chief Operating Officer
GALLAGHER JOHN R
Chief Operating Officer
Tooth Margaret
CEO
Tooth Margaret
CEO
GALLAGHER JOHN R
Chief Operating Officer
Qureshi Fawwad
Chief Financial Officer
Tooth Margaret
CEO
Tooth Margaret
CEO
Tooth Margaret
CEO
Tooth Margaret
CEO
Tooth Margaret
CEO
Tooth Margaret
CEO
RAWLINGS DARRYL
Director
RAWLINGS DARRYL
Director
Qureshi Fawwad
Chief Financial Officer
Qureshi Fawwad
Chief Financial Officer
MCGIBNEY BRENNA
Chief Administration Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 09, 2026 | Tooth Margaret CEO | Sale | 1,000 | $25.84 | $25,840 | |
| Sep 28, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 431 | $22.92 | $9,879 | |
| Sep 11, 2026 | Tooth Margaret CEO | Sale | 1,000 | $25.00 | $25,000 | |
| Aug 28, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 3,604 | $29.70 | $107,039 | |
| Aug 26, 2026 | Qureshi Fawwad Chief Financial Officer | Sale | 6,111 | $30.01 | $183,391 | |
| Aug 11, 2026 | Tooth Margaret CEO | Sale | 978 | $29.05 | $28,411 | |
| Jul 28, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 431 | $25.08 | $10,809 | |
| Jun 29, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 431 | $25.35 | $10,926 | |
| Jun 05, 2026 | WEINRAUCH STEVE EVP, North Am & Vet Strategy | Sale | 6,674 | $22.00 | $146,828 | |
| May 28, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 3,603 | $21.69 | $78,153 | |
| May 27, 2026 | Qureshi Fawwad Chief Financial Officer | Sale | 170 | $22.63 | $3,846 | |
| May 27, 2026 | Qureshi Fawwad Chief Financial Officer | Sale | 6,007 | $22.17 | $133,170 | |
| Apr 28, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 431 | $27.47 | $11,840 | |
| Mar 30, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 430 | $25.47 | $10,952 | |
| Mar 04, 2026 | DREYER EMILY Chief Revenue Officer | Sale | 7,792 | $28.15 | $219,320 | |
| Feb 27, 2026 | Qureshi Fawwad Chief Financial Officer | Sale | 2,837 | $26.46 | $75,075 | |
| Feb 27, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 5,283 | $26.52 | $140,080 | |
| Feb 25, 2026 | Qureshi Fawwad Chief Financial Officer | Sale | 4,645 | $25.61 | $118,958 | |
| Jan 28, 2026 | GALLAGHER JOHN R Chief Operating Officer | Sale | 430 | $31.67 | $13,618 | |
| Dec 29, 2025 | GALLAGHER JOHN R Chief Operating Officer | Sale | 430 | $37.55 | $16,147 | |
| Dec 19, 2025 | Tooth Margaret CEO | Sale | 1,605 | $37.91 | $60,845 | |
| Dec 19, 2025 | Tooth Margaret CEO | Sale | 8,000 | $37.88 | $303,005 | |
| Nov 28, 2025 | GALLAGHER JOHN R Chief Operating Officer | Sale | 6,383 | $34.82 | $222,283 | |
| Nov 26, 2025 | Qureshi Fawwad Chief Financial Officer | Sale | 6,202 | $35.45 | $219,837 | |
| Nov 25, 2025 | Tooth Margaret CEO | Sale | 1,803 | $35.31 | $63,664 | |
| Nov 25, 2025 | Tooth Margaret CEO | Sale | 8,000 | $35.31 | $282,480 | |
| Oct 27, 2025 | Tooth Margaret CEO | Sale | 2,884 | $43.74 | $126,153 | |
| Oct 27, 2025 | Tooth Margaret CEO | Sale | 6,000 | $43.72 | $262,340 | |
| Sep 25, 2025 | Tooth Margaret CEO | Sale | 2,961 | $41.88 | $124,003 | |
| Sep 25, 2025 | Tooth Margaret CEO | Sale | 6,000 | $41.89 | $251,315 | |
| Sep 04, 2025 | RAWLINGS DARRYL Director | Sale | 30,369 | $44.70 | $1,357,500 | |
| Sep 03, 2025 | RAWLINGS DARRYL Director | Sale | 19,631 | $44.79 | $879,225 | |
| Sep 02, 2025 | Qureshi Fawwad Chief Financial Officer | Sale | 6,451 | $45.15 | $291,294 | |
| Aug 26, 2025 | Qureshi Fawwad Chief Financial Officer | Sale | 2,800 | $45.56 | $127,574 | |
| Jun 02, 2025 | MCGIBNEY BRENNA Chief Administration Officer | Sale | 2,390 | $45.17 | $107,956 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.